Publications by authors named "Kalyan Sreeram"
Purpose: Improved life expectancy has increased the likelihood for long-term complications from chemotherapy among cancer survivors. One burdensome complication is chemotherapy-induced peripheral neuropathy (CIPN). We evaluated rates of CIPN outcomes in the Detroit Research on Cancer Survivorship (ROCS) cohort.
View Article and Find Full Text PDFArticle Synopsis
- A study of 2,420 breast cancer survivors revealed that many experience long-term side effects, particularly peripheral neuropathy (PN), after treatment.
- About 17% of participants reported PN symptoms, with 74% continuing to experience them an average of 6.5 years post-diagnosis, especially after chemotherapy.
- Chemotherapy, especially taxane drugs like paclitaxel and docetaxel, significantly increased the risk of developing PN compared to other treatment methods.
Background: Comorbidities play a key role in severe disease outcomes in COVID-19 patients. However, the literature on preexisting respiratory diseases and COVID-19, accounting for other possible confounders, is limited. The primary objective of this study was to determine the association between preexisting respiratory diseases and severe disease outcomes among COVID-19 patients.
View Article and Find Full Text PDF